Maisa Ziadni1, Abby L Chen1, Parthasarathy Krishnamurthy2, Pamela Flood1, Richard L Stieg3, Beth D Darnall1. 1. Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, CA, USA. 2. Department of Marketing and Entrepreneurship, CT Bauer College of Business, University of Houston, Houston, TX, USA. 3. LLC, Frisco, CO, USA.
Abstract
OBJECTIVE: We previously reported promising results for a 4-month patient-centered voluntary opioid tapering study. Key questions remain about the durability of effects and possible risks after opioid reduction. We provide the longest follow-up data to date for prospective opioid tapering: 2- to 3-year follow-up for pain intensity and daily opioid use in a subset of patients from our original 4-month opioid tapering study. METHODS: Twenty-three patients (44% of original sample) responded to contact attempts through telephone and reported their average pain intensity and current opioid use. Opioid doses were converted to morphine equivalent daily dose (MEDD). Data were analyzed within a repeated-measures model where time (baseline, 4 months, and 2-3 years) was the within-subject factor. RESULTS: Among reachable patients, the effect of time on change in MEDD from baseline to 4 months to 2 to 3 years was significant. Since baseline, 20 (95%) of the current sample reduced MEDD, and 15 (71%) further reduced MEDD at 2- to 3-year follow-up. There was no effect of time on change in pain intensity from baseline to 4 months to 2 to 3 years. Since baseline, 11 (52%) of the current sample reported pain reduction, and 12 (57%) reported reduced pain from the 4-month follow-up to the 2- to 3-year follow-up. Five (24%) reported increased pain intensity. CONCLUSION: Study findings reveal continued MEDD reduction and enduring pain stability 2 to 3 years after a patient-centered voluntary opioid tapering program for a substantial fraction of patients. Notably, we were not able to verify current opioid use through medical records and were limited by self-report.
OBJECTIVE: We previously reported promising results for a 4-month patient-centered voluntary opioid tapering study. Key questions remain about the durability of effects and possible risks after opioid reduction. We provide the longest follow-up data to date for prospective opioid tapering: 2- to 3-year follow-up for pain intensity and daily opioid use in a subset of patients from our original 4-month opioid tapering study. METHODS: Twenty-three patients (44% of original sample) responded to contact attempts through telephone and reported their average pain intensity and current opioid use. Opioid doses were converted to morphine equivalent daily dose (MEDD). Data were analyzed within a repeated-measures model where time (baseline, 4 months, and 2-3 years) was the within-subject factor. RESULTS: Among reachable patients, the effect of time on change in MEDD from baseline to 4 months to 2 to 3 years was significant. Since baseline, 20 (95%) of the current sample reduced MEDD, and 15 (71%) further reduced MEDD at 2- to 3-year follow-up. There was no effect of time on change in pain intensity from baseline to 4 months to 2 to 3 years. Since baseline, 11 (52%) of the current sample reported pain reduction, and 12 (57%) reported reduced pain from the 4-month follow-up to the 2- to 3-year follow-up. Five (24%) reported increased pain intensity. CONCLUSION: Study findings reveal continued MEDD reduction and enduring pain stability 2 to 3 years after a patient-centered voluntary opioid tapering program for a substantial fraction of patients. Notably, we were not able to verify current opioid use through medical records and were limited by self-report.
Authors: Michael K Nicholas; Ali Asghari; Louise Sharpe; Lee Beeston; Charles Brooker; Paul Glare; Rebecca Martin; Allan Molloy; Paul J Wrigley Journal: Pain Date: 2020-03 Impact factor: 6.961
Authors: Beth D Darnall; David Juurlink; Robert D Kerns; Sean Mackey; Brent Van Dorsten; Keith Humphreys; Julio A Gonzalez-Sotomayor; Andrea Furlan; Adam J Gordon; Debra B Gordon; Diane E Hoffman; Joel Katz; Stefan G Kertesz; Sally Satel; Richard A Lawhern; Kate M Nicholson; Rosemary C Polomano; Owen D Williamson; Heath McAnally; Ming-Chih Kao; Stephan Schug; Robert Twillman; Terri A Lewis; Richard L Stieg; Kate Lorig; Theresa Mallick-Searle; Robert W West; Sarah Gray; Steven R Ariens; Jennifer Sharpe Potter; Penney Cowan; Chad D Kollas; Danial Laird; Barby Ingle; J Julian Grove; Marian Wilson; Kashelle Lockman; Fiona Hodson; Carol S Palackdharry; Roger B Fillingim; Jeffrey Fudin; Jennifer Barnhouse; Ajay Manhapra; Steven R Henson; Bruce Singer; Marie Ljosenvoor; Marlisa Griffith; Jason N Doctor; Kimeron Hardin; Cathleen London; Jon Mankowski; Andrea Anderson; Linda Ellsworth; Lisa Davis Budzinski; Becky Brandt; Greg Hartley; Debbie Nickels Heck; Mark J Zobrosky; Celeste Cheek; Megan Wilson; Cynthia E Laux; Geralyn Datz; Justin Dunaway; Eileen Schonfeld; Melissa Cady; Thérèse LeDantec-Boswell; Meredith Craigie; John Sturgeon; Pamela Flood; Melita Giummarra; Jessica Whelan; Beverly E Thorn; Richard L Martin; Michael E Schatman; Maurice D Gregory; Joshua Kirz; Patti Robinson; James G Marx; Jessica R Stewart; Phillip S Keck; Scott E Hadland; Jennifer L Murphy; Mark A Lumley; Kathleen S Brown; Michael S Leong; Mechele Fillman; James W Broatch; Aaron Perez; Kristine Watford; Kari Kruska; Dokyoung Sophia You; Stacy Ogbeide; Amy Kukucka; Susan Lawson; James B Ray; T Wade Martin; James B Lakehomer; Anne Burke; Robert I Cohen; Peter Grinspoon; Marc S Rubenstein; Stephani Sutherland; Kristie Walters; Travis Lovejoy Journal: Pain Med Date: 2019-03-01 Impact factor: 3.750
Authors: Roger Chou; Judith A Turner; Emily B Devine; Ryan N Hansen; Sean D Sullivan; Ian Blazina; Tracy Dana; Christina Bougatsos; Richard A Deyo Journal: Ann Intern Med Date: 2015-02-17 Impact factor: 25.391
Authors: Kelly L Huffman; Taylor E Rush; Youran Fan; Giries W Sweis; Brinder Vij; Edward C Covington; Judith Scheman; Manu Mathews Journal: Pain Date: 2017-07 Impact factor: 6.961
Authors: Beth D Darnall; Maisa S Ziadni; Richard L Stieg; Ian G Mackey; Ming-Chih Kao; Pamela Flood Journal: JAMA Intern Med Date: 2018-05-01 Impact factor: 21.873
Authors: Joseph W Frank; Travis I Lovejoy; William C Becker; Benjamin J Morasco; Christopher J Koenig; Lilian Hoffecker; Hannah R Dischinger; Steven K Dobscha; Erin E Krebs Journal: Ann Intern Med Date: 2017-07-11 Impact factor: 25.391
Authors: Elizabeth M Oliva; Thomas Bowe; Ajay Manhapra; Stefan Kertesz; Jennifer M Hah; Patricia Henderson; Amy Robinson; Meenah Paik; Friedhelm Sandbrink; Adam J Gordon; Jodie A Trafton Journal: BMJ Date: 2020-03-04